Devices › Catheter, angioplasty, peripheral, transluminal
Device brand name · Pta balloon dilatation catheter
Ultraverse RX: medical device reports filed with FDA
369 reports name it, 2021–2026. Manufacturer given most often on reports: Bard Peripheral Vascular. Product code LIT.
- 369
- device reports naming the brand
- 0% of all MAUDE reports · about 74 a year
- 68
- reports, 12 months to August 2026
- 107 in the 12 months before
- 98.9%
- classified as malfunction
- 83.5% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 369 reports that name the brand "Ultraverse RX" (pta balloon dilatation catheter), received between July 2021 and August 2026; the manufacturer given most often on reports is Bard Peripheral Vascular. Spellings of one product vary from report to report.
68 reports arrived in the 12 months to August 2026, down 36% from 107 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (98.9%) and injury (1.1%); across all catheter, angioplasty, peripheral, transluminal reports (product code LIT) death is recorded in 0.5% and malfunction in 83.5%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are material rupture (77.2%), material deformation (11.7%) and failure to advance (8.7%). The patient problems coded most often are appropriate clinical signs, symptoms and conditions term/code not available. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 35,907 reports carrying product code LIT. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Material rupture | 285 | 77.2% | 44.2% |
| Material deformation | 43 | 11.7% | 1.3% |
| Failure to advance | 32 | 8.7% | 1.3% |
| Detachment of device or device componentpart of the device came off | 24 | 6.5% | 3.7% |
| Difficult to removethe device was hard to remove | 22 | 6% | 9.1% |
| Device-device incompatibility | 19 | 5.1% | 0.4% |
| Breakthe device broke | 15 | 4.1% | 3.2% |
| Material split, cut or torn | 8 | 2.2% | 0.5% |
| Deflation problem | 5 | 1.4% | 4.5% |
| Inflation problem | 5 | 1.4% | 4.1% |
| Leak/splashthe device leaked | 5 | 1.4% | 6.1% |
| Difficult to insertthe device was hard to insert | 3 | 0.8% | 0.6% |
| Material twisted/bent | 3 | 0.8% | 0.4% |
| Entrapment of device | 2 | 0.5% | 1.3% |
| Air/gas in device | 1 | 0.3% | 0% |
| Contamination | 1 | 0.3% | 0% |
| Device contamination with chemical or other material | 1 | 0.3% | 0.2% |
| Device dislodged or dislocated | 1 | 0.3% | 0.2% |
| Device markings/labelling problema problem with the device markings or label | 1 | 0.3% | 0.2% |
| Difficult to advance | 1 | 0.3% | 1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Appropriate clinical signs, symptoms and conditions term/code not available | 4 | 1.1% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Ultraverse RX | Product code LIT | All MAUDE reports |
|---|---|---|---|
| Reports | 369 | 35,907 | 26,136,888 |
| Share of that pool | — | 1% | 0% |
| Classified as death, per 1,000 reports | 0 | 5 | 9 |
| Classified as injury | 1.1% | 15.1% | 36.2% |
| Classified as malfunction | 98.9% | 83.5% | 62.3% |
| Filed by the manufacturer | 99.5% | 97.6% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LIT
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Coyote? ES | 5,428 | 438 | 0% |
| 2cm Peripheral Cutting Balloon | 3,202 | 314 | 0% |
| Armada 35 PTA Catheter | 1,864 | 9 | 0.2% |
| Sterling | 4,963 | 300 | 0.1% |
| Coyote? | 1,767 | 122 | 0.1% |
| Mustang | 5,969 | 491 | 0.3% |
| Armada 18 Pta Catheter | 651 | 0 | 0% |
| Armada | 680 | 305 | 0.1% |
| Gladiator? Elite | 545 | 59 | 0% |
| Armada 14 Pta Catheter | 746 | 0 | 0% |
| Ultra-Thin Balloon Dilatation Catheter | 488 | 0 | 0.4% |
| Fox Plus Pta Catheter | 385 | 0 | 0% |
| Evercross 035 | 427 | 30 | 2.6% |
| Sterling Es Pta Balloon Dilatation Catheter | 333 | 0 | 0% |
| Fox Sv Pta Catheter | 299 | 0 | 0.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Ultraverse RX reports
How many FDA reports name Ultraverse RX?
369 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 68 in the latest 12 months.
What kinds of events are reported?
malfunction (98.9%) and injury (1.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
material rupture (77.2%), material deformation (11.7%), failure to advance (8.7%), detachment of device or device component (6.5%) and difficult to remove (6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Ultraverse RX was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.